Log In
Print this Print this

biosimilar pegfilgrastim (CHS-1701)

  Manage Alerts
Collapse Summary General Information
Company Coherus BioSciences Inc.
DescriptionBiosimilar of pegfilgrastim, a pegylated G-CSF
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationNeutropenia
Indication DetailsReduce the incidence of febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today